Jonathan Powell
8Patents
3h-index
13Co-inventors
50Inventor score
Filing activity: Sep 8, 2008 → Jul 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9005629B2 | Method for treating cancer with an antibody to CD223 protein | Emerging Cross-Sectional Technologies | 38 | Active |
| US8551481B2 | Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody | Emerging Cross-Sectional Technologies | 34 | Active |
| US9585957B2 | Adenosine receptor agonists and antagonists to modulate T cell responses | Human Necessities | 5 | Active |
| US9523126B2 | Compositions and methods for modulating an immune response | Chemistry; Metallurgy | 2 | Active |
| US10787513B2 | Methods for treatment comprising an antibody that binds CD223 protein | Emerging Cross-Sectional Technologies | 1 | Active |
| US11639508B2 | Engineered TSC2 | Chemistry; Metallurgy | 0 | Active |
| US10329617B2 | Compositions and methods for modulating an immune response | Chemistry; Metallurgy | 0 | Active |
| US10934354B2 | Methods of increasing T cell immune response in the treatment of cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.